# Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

> **NCT01144975** · PHASE2 · COMPLETED · sponsor: **XOMA (US) LLC** · enrollment: 76 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** XOMA 052
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01144975
- **Lead sponsor:** XOMA (US) LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144975, "Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01144975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*